Methylthioadenosine/S-adenosylhomocysteine nucleosidase (Pfs) of Staphylococcus aureus is essential for the virulence independent of LuxS/AI-2 system

https://doi.org/10.1016/j.ijmm.2013.03.004Get rights and content

Abstract

Staphylococcus aureus is a major cause of infectious morbidity and mortality in both community and hospital settings. The bacterium continues to cause diverse invasive, life-threatening infections, such as pneumonia, endocarditis, and septicemia. Methylthioadenosine/S-adenosylhomocysteine nucleosidase (Pfs) is predicted to be an important enzyme involved in methylation reactions, polyamine synthesis, vitamin synthesis, and quorum sensing pathways. For the first time, we demonstrate that Pfs is essential for the virulence of S. aureus. The pfs mutant strain, as compared to the isogenic wild type, displayed a decreased production of extracellular proteases, which was correlated with a dramatic decrease in the expression of the sspABC operon and a moderate decrease of aur expression. The mouse model of sepsis and subcutaneous abscesses indicated that the pfs mutant strain displayed highly impaired virulence compared to the isogenic wild type. The decreased virulence of the pfs mutant strain is in correspondence with its decreased proliferation in vivo, indicated with a real-time analysis in the transparent system of zebrafish embryos. These phenotypes of the pfs mutant strain are LuxS/AI-2 independent despite the essential role pfs plays in AI-2 production. Our data suggest that Pfs is a potential novel target for anti-infection therapy.

Introduction

Staphylococcus aureus can induce diverse invasive, life-threatening infections, such as pneumonia, endocarditis and septicaemia (Bubeck Wardenburg et al., 2007, Panizzi et al., 2011), and is a major cause of infectious morbidity and mortality in both community and hospital settings (Boucher and Corey, 2008, David and Daum, 2010). The worldwide emergence of antibiotic resistant strains continues unabated, along with an overall increase in the number of infections worldwide (Fridkin et al., 2005, Jain et al., 2011), highlighting the urgent need for new agents for the treatment of S. aureus infection. Non-conventional anti-infective approaches have been explored that are non-lethal to bacteria, where the potential to develop resistance is assumed to be less significant (Maresso and Schneewind, 2008, Wyatt et al., 2010).

As an activated group donor, S-adenosylmethionine (SAM) is essential in a broad array of metabolic reactions, such as methylation reactions, polyamine synthesis, SAM radical-mediated vitamin synthesis, and N-acyl-homoserine lactone (autoinducer-1) synthesis (Parveen and Cornell, 2011) (Fig. 1). Methylthioadenosine (MTA) (Pajula and Raina, 1979), S-adenosylhomocysteine (SAH) (Simms and Subbaramaiah, 1991), and 5′-deoxyadenosine (5′dADO) (Choi-Rhee and Cronan, 2005) are product inhibitors of these reactions, and MTA/SAH nucleosidase (Pfs) is the enzyme that catalyses their irreversible hydrolytic deadenylation reaction in bacteria (Della Ragione et al., 1985). Methylthioadenosine/S-adenosylhomocysteine nucleosidase is widespread among bacteria (Winzer et al., 2002). Sun and co-workers showed that 51 out of 138 bacterial species with completely sequenced genomes possess cytoplasmic MTA/SAH nucleosidase (Sun et al., 2004). It was reported that the inhibition of MTA/SAH nucleosidase activity led to an accumulation of MTA and SAH within bacterial cells (Heurlier et al., 2009) and ended into the inhibition of SAM-dependent synthase activities. In addition, Pfs is involved in the recycling pathway of adenine, sulphur, and methionine, and it also produces the universal quorum-sensing signal, autoinducer-2 (AI-2) (Heurlier et al., 2009).

On the basis of its importance in a wide array of metabolic reactions and as an enzyme present in most bacterial species but absent in humans, Pfs is an attractive target for developing new classes of broad-spectrum inhibitors for the treatment of bacterial infections (Parveen and Cornell, 2011). An evaluation of the substrate analogs and transition state analogs effective against MTA/SAH nucleosidases of Borrelia burgdorferi, which uniquely expresses three homologous functional enzymes (Fraser et al., 1997, Parveen et al., 2006, Parveen and Leong, 2000), led to the identification of compounds that either inhibited the growth of these spirochaetes or showed bactericidal activities (Cornell et al., 2009). Using transition state analogs, the role of Pfs inhibitors has been explored in pathogenic strains of Vibrio cholera and Escherichia coli, where they can inhibit AI-2 production and reduce biofilm formation, but with minimal effect on bacterial growth (Gutierrez et al., 2009). These results indicate that the inhibition of this enzyme can affect the physiological activities of different bacteria. New inhibitors against Pfs are currently being explored for the development of potential novel broad-spectrum antimicrobials. However, despite this, the importance of Pfs independent of AI-2 remains generally underappreciated. Up to now, nothing is known about the role Pfs plays in the virulence of bacteria.

In S. aureus, the structure of Pfs was determined in a complex with the transition-state analog formycin A at a 1.7 Å resolution (Siu et al., 2008). It was highly conserved in the active-site residues and revealed an identical mode of inhibitor binding with available E. coli Pfs structures (Siu et al., 2008). Furthermore, it was confirmed that Pfs of S. aureus displays MTA and SAH nucleosidase activity (Siu et al., 2008). Besides this, the biological role of Pfs in the Staphylococcaceae family remains unknown.

AI-2, shared by both Gram-positive and Gram-negative bacteria, is generally considered to be a universal language for intraspecies and interspecies communication (Vendeville et al., 2005). S. aureus possesses a functional luxS gene, which has been proved to be essential for AI-2 production (Doherty et al., 2006, Winzer et al., 2002). In addition, S. aureus LuxS/AI-2 system has been reported to regulate a range of behaviors, such as virulence-associated traits (Zhao et al., 2010), biofilm formation (Yu et al., 2012), and susceptibility to cell wall synthesis inhibitor antibiotics (Xue et al., 2013).

In this study, we aim to prove that Pfs is essential for the virulence of S. aureus. A molecular genetics approach of targeted mutagenesis was used, and the pfs mutant strain was compared to the isogenic wild type strain with respect to the pathogenesis-related traits. It was found that the pfs mutation decreased the extracellular proteases expression of S. aureus. And the animal models of mouse and zebrafish were used to confirm that Pfs contributes to the pathogenicity of S. aureus. In addition, our results show that despite the essential role pfs plays in AI-2 production, these phenotypes of the pfs mutant strain is LuxS/AI-2 independent.

Section snippets

Bacterial strains and growth conditions

The phenotypic and genotypic properties of the bacterial strains and plasmids used in this study are listed in Table 1. The S. aureus strain RN4220, a restriction-deficient derivative of strain 8325-4, was used as the initial recipient for the transformation of plasmid constructs. All E. coli strains were grown in Luria Bertani (LB) medium (Oxoid), and all S. aureus strains were grown in tryptic soy broth (TSB) containing 0.25% glucose (Difco, Detroit, Mich.) at 37 °C with shaking, unless

The pfs gene expression is growth phase dependent

In S. aureus NCTC8325, pfs (SAOUHSC_01702) is present between two hypothetical proteins with unknown functions (http://www.ncbi.nlm.nih.gov/). Downstream of pfs are a GTP-binding proteins containing YqeH (SAOUHSC_01700), a shikimate 5-dehydrogenase (SAOUHSC_01699), a nicotinate (nicotinamide) nucleotide adenylyltransferase (SAOUHSC_01697), a DNA internalization-related competence protein (SAOUHSC 01691), and seven hypothetical proteins. Upstream of pfs are an enterotoxin family protein

Discussion

Nowadays, the incessant emergence of antibiotic resistant strains has created new challenges in the treatment of bacterial infection. Despite its central role in cellular metabolism and quorum sensing, the importance of MTA/SAH nucleosidase (Pfs) in bacteria has only started to become appreciated in the past decade (Parveen and Cornell, 2011), and very little is known about the biological function of Pfs independent of the autoinducer AI-2. This study focused on revealing that Pfs plays an

Acknowledgments

We thank the Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA) for providing the bacterial strains. This work was supported by the National Natural Science Foundation of China (grants 31070116 and 31021061).

References (49)

  • K.N. Adams et al.

    Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism

    Cell

    (2011)
  • L.L. Anzaldi et al.

    The evolution of a superbug: how Staphylococcus aureus overcomes its unique susceptibility to polyamines

    Mol. Microbiol.

    (2011)
  • K.E. Beenken et al.

    Epistatic relationships between sarA and agr in Staphylococcus aureus biofilm formation

    PLoS One

    (2010)
  • H.W. Boucher et al.

    Epidemiology of methicillin-resistant Staphylococcus aureus

    Clin. Infect. Dis.

    (2008)
  • G. Brackman et al.

    Structure–activity relationship of cinnamaldehyde analogs as inhibitors of AI-2 based quorum sensing and their effect on virulence of Vibrio spp.

    PLoS One

    (2011)
  • R. Brückner

    Gene replacement in Staphylococcus carnosus and Staphylococcus xylosus

    FEMS Microbiol. Lett.

    (1997)
  • J. Bubeck Wardenburg et al.

    Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia

    Nat. Med.

    (2007)
  • E. Choi-Rhee et al.

    A nucleosidase required for in vivo function of the S-adenosyl-l-methionine radical enzyme, biotin synthase

    Chem. Biol.

    (2005)
  • K.A. Cornell et al.

    Assessment of methylthioadenosine/S-adenosylhomocysteine nucleosidases of Borrelia burgdorferi as targets for novel antimicrobials using a novel high-throughput method

    J. Antimicrob. Chemother.

    (2009)
  • S.N. Coulter et al.

    Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments

    Mol. Microbiol.

    (1998)
  • M.Z. David et al.

    Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic

    Clin. Microbiol. Rev.

    (2010)
  • F. Della Ragione et al.

    Escherichia coli S-adenosylhomocysteine/5′-methylthioadenosine nucleosidase. Purification, substrate specificity and mechanism of action

    Biochem. J.

    (1985)
  • N. Doherty et al.

    Functional analysis of luxS in Staphylococcus aureus reveals a role in metabolism but not quorum sensing

    J. Bacteriol.

    (2006)
  • G. Dubin

    Extracellular proteases of Staphylococcus spp.

    Biol. Chem.

    (2002)
  • C.M. Fraser et al.

    Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi

    Nature

    (1997)
  • S.K. Fridkin et al.

    Methicillin-resistant Staphylococcus aureus disease in three communities

    N. Engl. J. Med.

    (2005)
  • I. Gjertsson et al.

    Formylated peptides are important virulence factors in Staphylococcus aureus arthritis in mice

    J. Infect. Dis.

    (2012)
  • J.A. Gutierrez et al.

    Transition state analogs of 5′-methylthioadenosine nucleosidase disrupt quorum sensing

    Nat. Chem. Biol.

    (2009)
  • K. Heurlier et al.

    Growth deficiencies of Neisseria meningitidis pfs and luxS mutants are not due to inactivation of quorum sensing

    J. Bacteriol.

    (2009)
  • P. Hruz et al.

    NOD2 contributes to cutaneous defense against Staphylococcus aureus through {alpha}-toxin-dependent innate immune activation

    Proc. Natl. Acad. Sci. U. S. A.

    (2009)
  • R. Jain et al.

    Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections

    N. Engl. J. Med.

    (2011)
  • G.Y. Liu et al.

    Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity

    J. Exp. Med.

    (2005)
  • A.W. Maresso et al.

    Sortase as a target of anti-infective therapy

    Pharmacol. Rev.

    (2008)
  • M.J. McGavin et al.

    Modification of the Staphylococcus aureus fibronectin binding phenotype by V8 protease

    Infect. Immun.

    (1997)
  • Cited by (29)

    • Characterization of S-adenosylhomocysteine/Methylthioadenosine nucleosidase on secretion of AI-2 and biofilm formation of Escherichia coli

      2017, Microbial Pathogenesis
      Citation Excerpt :

      S-adenosylhomocysteine/Methylthioadenosine nucleosidase (SAHN E.C.3.2.2.9) is not present in mammalian cells but is essential for methyl recycling in numerous bacterial and protozoan species (Fig. 1). Because of its prevalence in most bacterial pathogens of humans, attention has turned to the enzyme as a target for the development of drugs to selectively block microbial methyl metabolism [3–5]. S-adenosylhomocysteine (SAH) and methylthioadenosine (MTA), byproducts of S-adenosylmethionine (SAM) -dependent methylation reactions and polyamine biosynthesis, are both product inhibitors of SAM-involved reaction (Fig. 1) [6].

    View all citing articles on Scopus
    View full text